Thought Leadership
Little Impact Post-Arthrex for Biologic Patents at the PTAB
December 3, 2019
Stacie Ropka and Gabriella McIntyre
The Center for Biosimilars

Axinn partner Stacie Ropka and associate Gabriella McIntyre co-authored The Center for Biosimilars article, "Little Impact Post-Arthrex for Biologic Patents at the PTAB."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.